Form 4 for MGRX MANGOCEUTICALS, INC.
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-01 · accession 0001493152-23-015393 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-04 | 2023-05-01 | MGRX | Hammer Amanda Elizabeth | COO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2023-05-04 | 2023-05-01 | MGRX | Hammer Amanda Elizabeth | COO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | A | A | 75,000 | $0.00 | 75,000 | D | — | — | (F1) Issued as a sign-on bonus for agreeing to become the Chief Operating Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-05-01 | A | A | 150,000 | $0.00 | 150,000 | D | $1.10 · — to 2033-05-01 | 150,000 Common Stock | (F3) The options vest at the rate of 1/3rd of such options on each of May 1, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Company on such vesting dates. |